N-(2-(DIETHYLAMINO)ETHYL)-5-FLUOROPICOLINAMIDE, 95%, 100mg

2-(4-FLUOROPHENOXY)BENZYLAMINE HCL, 95.0%, 1g

BENZAMIDE, N-CYCLOPROPYL-4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-, 95.0%, 250mg

2-(4-Methoxyphenyl)acetyl chloride, 98.0%, 5g

Mal-AMCHC, 99.0%, 1g

Methyl 5-amino-2-methylpyridine-3-carboxylate, 98+%, 5g

4-Methylpyridine-3-sulfonic acid, 95.0%, 10g

4-Bromo-5-chloro-6-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98%, 5g

2-(4-Thiazolyl)benzimidazole>98.0%(GC)(T)250g

Methyl 2-(methylsulfonyl)benzoate, 95%, 1g

(4S,4'S)-1,1'-Bis(3,5-bis(trifluoromethyl)phenyl)-4,4'-diisopropyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 100mg

Plan PLPH 20x/0.40 phase contrast objective

2-Iodo-N-methoxy-N-methyl-4-nitrobenzamide, 97%, 1g